Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma

HPB

Volumn 16, Issue 7, 2014, Pages 677-685

  Thomas, Ryan M ^a,b   Aloia, Thomas A ^c   Truty, Mark J ^d   Tseng, Warren H ^c   Choi, Eugene A ^e   Curley, Steven A ^c   Vauthey, Jean N ^c   Abdalla, Eddie K ^f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Mayo Clinic College of Medicine   (United States)

^e UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^f LEBANESE AMERICAN UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CD31 ANTIGEN; CD34 ANTIGEN; CELECOXIB; INTERFERON; PACLITAXEL; THALIDOMIDE; TUMOR NECROSIS FACTOR; ANTINEOPLASTIC AGENT;

ADULT; AGED; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEMANGIOENDOTHELIOMA; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER SARCOMA; LIVER TRANSPLANTATION; LUNG METASTASIS; MALE; OBSERVATION; ORTHOTOPIC TRANSPLANTATION; OVERALL SURVIVAL; PREDICTOR VARIABLE; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SKIN METASTASIS; SURVIVAL RATE; SYSTEMIC THERAPY; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; ADOLESCENT; ARTIFICIAL EMBOLISM; HEMANGIOENDOTHELIOMA, EPITHELIOID; LIVER NEOPLASMS; LIVER RESECTION; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; SECONDARY; TIME; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL; VERY ELDERLY; WATCHFUL WAITING; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEMANGIOENDOTHELIOMA, EPITHELIOID; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TEXAS; TIME FACTORS; TREATMENT OUTCOME; WATCHFUL WAITING; YOUNG ADULT;

EID: 84902545951     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12202     Document Type: Conference Paper

References (24)

1. Makhlouf HR, Ishak KG, Goodman ZD,. (1999) Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer 85: 562-582.
2. Haydon E, Haydon G, Bramhall S, Mayer AD, Niel D,. (2005) Hepatic epithelioid haemangioendothelioma. J R Soc Med 98: 364-365.
3. Läuffer JM, Zimmermann A, Krähenbühl L, Triller J, Baer HU,. (1996) Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor. Cancer 78: 2318-2327.
4. Pokharna RK, Garg PK, Gupta SD, Dutta U, Tandon RK,. (1997) Primary epithelioid haemangioendothelioma of the liver: case report and review of the literature. J Clin Pathol 50: 1029-1031.
5. Ben-Haim M, Roayaie S, Ye MQ, Thung SN, Emre S, Fishbein TA, et al. (1999) Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg 5: 526-531.
6. Frider B, Bruno A, Selser J, Vanesa R, Pascual P, Bistoletti R,. (2005) Kasabach-Merrit syndrome and adult hepatic epithelioid hemangioendothelioma an unusual association. J Hepatol 42: 282-283.
7. Hayashi Y, Inagaki K, Hirota S, Yoshikawa T, Ikawa H,. (1999) Epithelioid hemangioendothelioma with marked liver deformity and secondary Budd-Chiari syndrome: pathological and radiological correlation. Pathol Int 49: 547-552.
8. Mascarenhas RCV, Sanghvi AN, Friedlander L, Geyer SJ, Beasley HS, Van Thiel DH,. (2004) Thalidomide inhibits the growth and progression of hepatic epithelioid hemangioendothelioma. Oncology 67: 471-475.
9. Galvão FHF, Bakonyi-Neto A, Machado MAC, Farias AQ, Mello ES, Diz ME, et al. (2005) Interferon alpha-2B and liver resection to treat multifocal hepatic epithelioid hemangioendothelioma: a relevant approach to avoid liver transplantation. Transplant Proc 37: 4354-4358.
10. Idilman R, Dokmeci A, Beyler AR, Bastemir M, Ormeci N, Aras N, et al. (1997) Successful medical treatment of an epithelioid hemangioendothelioma of liver. Oncology 54: 171-175.
11. St Peter SD, Moss AA, Huettl EA, Leslie KO, Mulligan DC,. (2003) Chemoembolization followed by orthotopic liver transplant for epithelioid hemangioendothelioma. Clin Transplant 17: 549-553.
12. Otrock ZK, Al-Kutoubi A, Kattar MM, Zaatari G, Soweid A,. (2006) Spontaneous complete regression of hepatic epithelioid haemangioendothelioma. Lancet Oncol 7: 439-441.
13. Grotz TE, Nagorney D, Donohue J, Que F, Kendrick M, Farnell M, et al. (2010) Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB 12: 546-553.
14. Lerut JP, Orlando G, Adam R, Schiavo M, Klempnauer J, Mirza D, et al. (2007) The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry. Ann Surg 246: 949-957.
15. Lerut JP, Orlando G, Sempoux C, Ciccarelli O, Van Beers BE, Danse E, et al. (2004) Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation. Transpl Int 17: 202-207.
16. Rodriguez JA, Becker NS, O'Mahony CA, Goss JA, Aloia TA,. (2008) Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg 12: 110-116.
17. Weitz J, Klimstra DS, Cymes K, Jarnagin WR, D'Angelica M, La Quaglia MP, et al. (2007) Management of primary liver sarcomas. Cancer 109: 1391-1396.
18. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, et al. (2006) Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer 107: 2108-2121.
19. Ishak KG, Sesterhenn IA, Goodman ZD, Rabin L, Stromeyer FW,. (1984) Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol 15: 839-852.
20. García-Botella A, Díez-Valladares L, Martín-Antona E, Sánchez-Pernaute A, Pérez-Aguirre E, Ortega L, et al. (2006) Epithelioid hemangioendothelioma of the liver. J Hepatobiliary Pancreat Surg 13: 167-171.
21. Dighe MK, Parnell S, Yeh MM, Lalani T,. (2004) Hepatic epitheloid hemangioendothelioma: multiphase CT appearance and correlation with pathology. Crit Rev Comput Tomogr 45: 343-354.
22. Kehagias DT, Moulopoulos LA, Antoniou A, Psychogios V, Vourtsi A, Vlahos LJ,. (2000) Hepatic epithelioid hemangioendothelioma: MR imaging findings. Hepato-gastroenterology 47: 1711-1713.
23. Wang L-R, Zhou J-M, Zhao Y-M, He H-W, Chai Z-T, Wang M, et al. (2012) Clinical experience with primary hepatic epithelioid hemangioendothelioma: retrospective study of 33 patients. World J Surg 36: 2677-2683.
24. Mehrabi A, Kashfi A, Schemmer P, Sauer P, Encke J, Fonouni H, et al. (2005) Surgical treatment of primary hepatic epithelioid hemangioendothelioma. Transplantation 1 (Suppl.): S109-S112.